drug

Japanese pharmaceutical company tries to ban generic versions of Prograf drug to extend its monopoly

Saturday, February 11, 2012 by: Ethan A. Huff, staff writer
Tags: Japan, pharmaceutical company, monopoly

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
Biologist explains how marijuana causes tumor cells to commit suicide
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
Companies begin planting microchips under employees' skin
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
Chemotherapy kills cancer patients faster than no treatment at all
Why flu shots are the greatest medical fraud in history
600 strains of an aerosolized thought control vaccine already tested on humans; deployed via air, food and water
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
Flu vaccine kills 13 in Italy; death toll rises
The 21 curious questions we're never allowed to ask about vaccines
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Whooping cough outbreak at Massachusetts high school affected only vaccinated students

Delicious
(NaturalNews) A group of consumers has filed a class-action lawsuit against Japanese pharmaceutical company Astellas Pharma for presenting what they say is a "sham" petition to the U.S. Food and Drug Administration (FDA) to extend the market exclusivity period for its transplant drug Prograf. According to Courthouse News Service, the lawsuit alleges that Astellas filed its petition not out of a concern for public health, but rather to simply extend its monopoly on the overpriced drug, which reportedly rakes in nearly $1 billion a year for Astellas.

Astellas "filed a baseless citizen petition with the FDA with the sole intent of foreclosing market entry by generic competitors, that improperly extended its monopoly and kept Prograf prices at supra-competitive levels," says the complaint. And this petition served as a placeholder for Astellas to continue marketing the drug at inflated prices, as the FDA reportedly took almost two years to provide a proper response.

During this time, Astellas raked in millions more than it would have if the market's exclusivity period would have run its natural course and expired. As a result, plaintiffs in the case, which also include insurance companies that were bilked by artificially-high prices for the drug, are seeking legal remedy for Astellas' alleged criminal behavior.

This is precisely how most drug companies work, though. Not content with simply playing by the same rules as everyone else, they rely on exclusive patents that allow them to make obscene profits on monopoly drugs that cost pennies on the dollar to produce. And as appears to be the case with Astellas, they are more than willing to milk the legal system as much as possible in order to maintain monopoly control over their drugs for as long as possible.

In an attempt to deflect the lawsuits filed against the company, Astellas petitioned for their dismissal citing supposed First Amendment rights. But in her ruling on the case, U.S. District Judge Rya Zobel explained that "[w]hen petitioning conduct is a mere sham to cover what is actually nothing more than an attempt to interfere directly with the business relationship of a competitor, such conduct is not immune."

Prograf is a drug given to transplant patients to prevent rejection of vital organs. It works by deliberately lowering immune function, and its many negative side effects include decreased urination, back pain, bloody urine, chronic fatigue, muscle problems, neurological damage, diabetes, severe allergies, and even death.

Sources for this article include:

http://www.courthousenews.com/2012/02/08/43724.htm

http://www.fiercepharma.com

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.